PET MRI Radiopharmaceuticals, Detroit
- Response deadline
- Sep 23, 2026 Due in 2 days
- Date posted
- Sep 21, 2026
- Source
- Open notice
Description
Special Notice Page 4 of 4 INTENT TO SOLE SOURCE The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees. The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2026, through September 30, 2027. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients. Product Name UoM Est. Annual Quantity Cu-64 Dotatate (Detectnet) 3-5 mCi Dose 15 F18 PSMA (Pylarify) 8-10 mCi Dose 120 F18 Fluorodeoxyglucose (FDG) 8-10 mCi Dose 200 F18 Neuraceq 8-10 mCi Dose 20 Pylarify (PSMA) Cancellation Fee N/A 22 It is the Government s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25026Q0931 was sent out to prospective vendors, with a reply window of August 18, 2026 through August 20, 2026. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested persons may identify their interests and capability to respond to this requirement no later than 4:00 PM Eastern Time, Wednesday, September 23, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government. Interest/capability statements shall be submitted to James Howard, Contracting Specialist, via e-mail at james.howard3@va.gov. Telephone inquiries will not be accepted.
Classifications
Documents (1)
- 36C25026Q1039.docx.docx16 KBNot yet available
Contacts
- James Howard
Similar contracts
- Morphine Sulfate Solution
- SNS Pharmaceutical Logistic Replenishment RequirementNew YorkDue Sep 22, 2026
- Glipizide TabletsDue Oct 8, 2026
- SNS Pharmaceutical Logistic Replenishment RequirementNew YorkDue Sep 21, 2026
- Philadelphia VA Medical Center RadiopharmacueticalsPennsylvaniaDue Sep 21, 2026
- Progesterone CapsulesDue Oct 2, 2026